Penn ENT

Forecast & Rating20 analysts currently cover Penn ENT, with about 60.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $23.45, about 11.2% upside from the current price of $21.08. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 21.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Penn ENT closely still see room for the stock to rise. Data as of Jul 28, 2026; for reference only and not investment advice.